Composition for the sustained and controlled release of medicame

Details Composition for the sustained and controlled release of medicame Composition for the sustained and controlled release of medicame

1994-03-16

1997-06-10

Tsang, Cecilia J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

530328, 424489, 424490, 424491, A61K 3800

Patent

active

056375689

ABSTRACT:
A composition designed for the sustained and controlled release of medicamentous peptide substances having the formula (I):

REFERENCES:
patent: 3737337 (1973-06-01), Schnoring et al.
patent: 3891570 (1975-06-01), Fukushima et al.
patent: 3976071 (1976-08-01), Sadek
patent: 4341767 (1982-07-01), Nestor et al.
patent: 4384975 (1983-05-01), Fong
patent: 4389330 (1983-06-01), Tice et al.
patent: 4652441 (1987-03-01), Okada et al.
patent: 4835139 (1989-05-01), Tice et al.
patent: 4954298 (1990-09-01), Yamamoto
patent: 5134122 (1992-07-01), Orsolini
patent: 5187150 (1993-02-01), Speiser et al.
patent: 5192741 (1993-03-01), Orsolini et al.
patent: 5445832 (1995-08-01), Orsolini et al.
Bajusz, et al, "New Antagonists of LHRH", Int. J. Peptide Protein Res. 32, 1988, 425-435.

Affiliated with

Also associated with

Rating

Composition for the sustained and controlled release of medicame does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Composition for the sustained and controlled release of medicame, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition for the sustained and controlled release of medicame will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-764662